Myc linked to dysregulation of cholesterol transport and storage in nonsmall cell lung cancer

• Main Authors: Zoe Hall, Catherine H. Wilson, Deborah L. Burkhart, Tom Ashmore, Gerard I. Evan, Julian L. Griffin
• Format: Article
• Language: English
• Published: Elsevier 2020-11-01
• Series: Journal of Lipid Research
• Subjects: cholesteryl ester; liquid extraction surface analysis; mass spectrometry; lipid metabolism; adenocarcinoma
• Online Access: http://www.sciencedirect.com/science/article/pii/S0022227520437277

Nonsmall cell lung cancer (NSCLC) is a leading cause of cancer-related deaths. While mutations in Kras and overexpression of Myc are commonly found in patients, the role of altered lipid metabolism in lung cancer and its interplay with oncogenic Myc is poorly understood. Here we use a transgenic mouse model of Kras-driven lung adenocarcinoma with reversible activation of Myc combined with surface analysis lipid profiling of lung tumors and transcriptomics to study the effect of Myc activity on cholesterol homeostasis. Our findings reveal that the activation of Myc leads to the accumulation of cholesteryl esters (CEs) stored in lipid droplets. Subsequent Myc deactivation leads to further increases in CEs, in contrast to tumors in which Myc was never activated. Gene expression analysis linked cholesterol transport and storage pathways to Myc activity. Our results suggest that increased Myc activity is associated with increased cholesterol influx, reduced efflux, and accumulation of CE-rich lipid droplets in lung tumors. Targeting cholesterol homeostasis is proposed as a promising avenue to explore for novel treatments of lung cancer, with diagnostic and stratification potential in human NSCLC.